Paxil 20 is the original branded formulation of paroxetine, a widely prescribed selective serotonin reuptake inhibitor (SSRI) recognized for its strong efficacy and reliable safety profile. This formulation offers consistent serotonin regulation in the brain, aiding in stabilizing mood, reducing anxiety, and managing various psychiatric disorders. It is trusted globally for treating depression and anxiety-related conditions with proven long-term benefits.

- Sleep & Mental Health > Depression, Anxiety, PTSD Paxil 20 is clinically proven to alleviate symptoms of major depressive disorder (MDD), generalized anxiety disorder (GAD), panic disorder, and post-traumatic stress disorder (PTSD). It promotes emotional stability and helps patients manage stress and mood swings effectively. > Obsessive-Compulsive Disorder (OCD) As an FDA-approved SSRI for OCD, Paxil 20 effectively reduces compulsive behaviors and intrusive thoughts by modulating serotonin pathways, helping patients regain control over obsessive symptoms. > Panic Disorder Paxil 20 is a frontline treatment for panic disorder, reducing the frequency and severity of panic attacks and minimizing the risk of recurrence through sustained serotonin enhancement.

Paxil 20 works by selectively inhibiting the serotonin reuptake transporter in the central nervous system, increasing serotonin availability in synaptic clefts. This elevation facilitates improved neurotransmission, enhancing mood, reducing anxiety, and restoring neurochemical balance in affected individuals.

Adult Dosing - Depression & Major Depressive Disorder (MDD): IR: Start 20 mg daily; Maintenance 20–50 mg; Max 50 mg CR: Start 25 mg daily; Maintenance 25–62.5 mg; Max 62.5 mg Dose may increase weekly by 10 mg (IR) or 12.5 mg (CR). Treatment typically lasts several months with efficacy demonstrated for up to 1 year. - Social Anxiety Disorder (SAD): IR: Start 20 mg daily; Maintenance 20–60 mg; Max 60 mg CR: Start 12.5 mg daily; Maintenance 12.5–37.5 mg; Max 37.5 mg Treatment duration up to 12 weeks, with weekly dose adjustments. - Panic Disorder (PD): IR: Start 10 mg daily; Maintenance 10–40 mg; Max 60 mg CR: Start 12.5 mg daily; Maintenance 12.5–75 mg; Max 75 mg Effective up to 12 weeks, dose escalations weekly. - Premenstrual Dysphoric Disorder (PMDD): CR only; Continuous dosing 12.5–25 mg daily or cyclic regimen starting 14 days pre-menses. Effective for at least 3 cycles, with possible dose escalation. - Obsessive Compulsive Disorder (OCD): IR: Start 20 mg daily; Maintenance 20–60 mg; Max 60 mg Chronic treatment recommended; weekly dose increments of 10 mg. - Post-Traumatic Stress Disorder (PTSD) & Generalized Anxiety Disorder (GAD): IR: Start 20 mg daily; Maintenance 20–50 mg; Max 50 mg Treatment duration up to 12 weeks, with weekly dose increases. - Postmenopausal Symptoms: Mesylate capsules at 7.5 mg daily, indicated for vasomotor symptoms only. Geriatric Dosing - Generally start at 10 mg daily with maintenance doses up to 40 mg/day for depression, OCD, PTSD, SAD, GAD, and panic disorder. - Weekly dose increases are recommended based on tolerance. - Not advised for mild or transient anxiety linked to everyday stress.

Store at room temperature, below 30°C (86°F), in a dry place away from direct sunlight and moisture. Keep the medication in its original packaging and out of reach of children to preserve efficacy and prevent accidental ingestion.

Common side effects include nausea, dizziness, drowsiness, dry mouth, sweating, sexual dysfunction, weight gain, and fatigue. Less common but serious adverse reactions may include serotonin syndrome, increased risk of bleeding, withdrawal symptoms upon abrupt discontinuation, and suicidal thoughts especially in younger patients. Monitoring by healthcare professionals is advised during treatment.